AstraZeneca PLC (AZN)
161.84
-0.29
(-0.18%)
USD |
NYSE |
Sep 01, 10:30
AstraZeneca Cash from Operations (Annual) : 14.90B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.90B |
| December 31, 2024 | 12.21B |
| December 31, 2023 | 10.63B |
| December 31, 2022 | 9.868B |
| December 31, 2021 | 5.997B |
| December 31, 2020 | 4.846B |
| December 31, 2019 | 3.093B |
| December 31, 2018 | 2.811B |
| December 31, 2017 | 3.742B |
| December 31, 2016 | 4.285B |
| December 31, 2015 | 3.441B |
| December 31, 2014 | 7.198B |
| December 31, 2013 | 7.477B |
| December 31, 2012 | 7.137B |
| December 31, 2011 | 7.981B |
| December 31, 2010 | 10.87B |
| December 31, 2009 | 11.78B |
| December 31, 2008 | 8.926B |
| Date | Value |
|---|---|
| December 31, 2007 | 7.868B |
| December 31, 2006 | 8.045B |
| December 31, 2005 | 6.949B |
| December 31, 2004 | 4.953B |
| December 31, 2003 | 3.427B |
| December 31, 2002 | 4.844B |
| December 31, 2001 | 3.126B |
| December 31, 2000 | 3.57B |
| December 31, 1999 | 1.312B |
| December 31, 1998 | 1.493B |
| December 31, 1997 | 1.372B |
| December 31, 1996 | 1.208B |
| December 31, 1995 | 1.051B |
| December 31, 1994 | 1.026B |
| December 31, 1993 | 969.93M |
| December 31, 1992 | 291.39M |
| December 31, 1991 | 474.31M |
| December 31, 1990 | 742.41M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| GSK Plc | 9.625B |
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Novo Nordisk A/S | 18.01B |